Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $5.14 in the prior trading day, AVITA Medical Inc (NASDAQ: RCEL) closed at $4.94, down -3.89%. In other words, the price has decreased by -$3.89% from its previous closing price. On the day, 0.6 million shares were traded. RCEL stock price reached its highest trading level at $5.17 during the session, while it also had its lowest trading level at $4.77.
Ratios:
Our goal is to gain a better understanding of RCEL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.72 and its Current Ratio is at 2.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on December 24, 2024, initiated with a Buy rating and assigned the stock a target price of $25.
On June 27, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $23.Cantor Fitzgerald initiated its Overweight rating on June 27, 2023, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’25 when McNamara Robert bought 11,000 shares for $8.30 per share. The transaction valued at 91,300 led to the insider holds 56,749 shares of the business.
McNamara Robert bought 10,000 shares of RCEL for $100,900 on Feb 20 ’25. The Director now owns 45,749 shares after completing the transaction at $10.09 per share. On Feb 20 ’25, another insider, O’Toole David D, who serves as the CFO of the company, bought 1,000 shares for $9.90 each. As a result, the insider paid 9,900 and bolstered with 25,734 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCEL now has a Market Capitalization of 135874208 and an Enterprise Value of 148842208. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.71. Its current Enterprise Value per Revenue stands at 2.077 whereas that against EBITDA is -2.991.
Stock Price History:
The Beta on a monthly basis for RCEL is 1.54, which has changed by -0.37861633 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, RCEL has reached a high of $14.16, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is -32.63%, while the 200-Day Moving Average is calculated to be -48.75%.
Shares Statistics:
The stock has traded on average 257.24K shares per day over the past 3-months and 300800 shares per day over the last 10 days, according to various share statistics. A total of 26.43M shares are outstanding, with a floating share count of 24.55M. Insiders hold about 1.18% of the company’s shares, while institutions hold 28.51% stake in the company. Shares short for RCEL as of 1748563200 were 3960286 with a Short Ratio of 15.40, compared to 1745971200 on 2974627. Therefore, it implies a Short% of Shares Outstanding of 3960286 and a Short% of Float of 15.100000999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
